Sesen Bio Inc.

NASDAQ:SESN 4:00:00 PM EDT

0.54

-0.01 (-1.27%)

7:38:00 PM EDT: $0.54 +0.01 (+0.94%)

Sesen Bio Inc. Stock, NASDAQ:SESN

245 First Street, Suite 1800, Cambridge, Massachusetts 02142

United States of America

Phone: +1.617.444.8550

Number of Employees: 35

http://www.sesenbio.com

Description

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.